Ascension St. Vincent’s uses new technology to treat AFib in clinical trial

 Ascension St. Vincent’s uses new technology to treat AFib in clinical trial

JACKSONVILLE, Fla. – The CDC estimates that more than 12 million people will have AFib by 2030.

AFib is short for Atrial fibrillation, which is an irregular and usually rapid heart rhythm that can lead to a pulsation of blood in the heart.

The Ascension St. Vincent’s is one of only five hospitals in the United States to enroll patients in a trial that studies how artificial intelligence changes how Afib is treated.

The new technology is called “Volta VX1.” It provides doctors like Saumil Oza of Ascension St. Vincent’s is a new way to treat patients with AFib.

“It computes through a separate system of electrical signatures,” Oza said. “It analyzes them. It guides us and marks the parts of the heart that it feels are important for us to operate on. Many of these places are places I would not have thought to visit. ”

This seems to be doing the job for Steven Preis, who has been dealing with Afib for a number of years. He had a serious period more than a decade ago.


“I went to the emergency room, and I was out of breath, the only thing I could get out of my mouth was‘ heat, ’” Preis said. “I remember my son saying, ‘Dad, I can see your heart beating in your chest.’”

People with Afib often have an increased risk of stroke, heart failure, and other heart -related complications.

According to Dr. Oza that this new way of treating AFib patients is a breath of fresh air when other methods like ablation are not available to patients like Preis.

“It really gives me another tool to help my patients,” he said. “The ultimate goal is to make my patients feel better, and live longer and healthier, more productive lives. AFib really puts a damper on that.”

Preis was one of more than 30 patients in the Jacksonville area to receive treatment. Preis said his Afib is now gone.

The way he made sure was to go to the Giants-Buccaneers game last NFL season with his son.

“We were walking and yes, I was undressing and undressing a little bit,” Preis said. “But then it started to get better, and better, and better. Now I can be outside when it’s damp, and not swell up and have a hard time and have a hard time breathing.


Despite the testing phase for this new treatment-Dr. believes. Oza with promise.

“It gives a lot of patients hope that otherwise, we don’t really have a lot of responses,” Oza said.

“There’s a light at the top of the tunnel,” Preis said. “You don’t have to have AFib anymore.”

Oza said he and his team will use and analyze this technology shortly. He expects enrollment for the clinical trial should be completed next year.

Copyright 2022 by WJXT News4JAX – All rights reserved.

Source link

Related post